📊 Score Breakdown
Offering Ability
40
Cash Runway
10
Float Risk
30
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for BAFN.
💹 Market Data
Market Cap$33.31M
Shares Outstanding5.37M
Float3.50M
Cash$134.47M
Debt$20.58M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↓ 5.1% shares (2025Q4 vs prior)
14 institutional holders · 605.1K shares
#1
VANGUARD GROUP INC
171.2K shares
#2
FIRST MANHATTAN CO. LLC.
127.9K shares
#3
BANC FUNDS CO LLC
91.7K shares
+ 11 more holders Sign up free to view →
📉 Short Interest
Short Interest258.4K
Days to Cover2.0
% of Float7.4%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
xbrl
XBRL CONVERTIBLE
Dec 31, 2021
S-1
SHELF
Apr 30, 2026
8-K
8K EVENT
Apr 30, 2026
4
INSIDER TRANSACTION
Feb 06, 2026
4
INSIDER TRANSACTION
Feb 06, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for BAFN
📊 BAFN FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 BAFN Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.